Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Alector, Inc.Listing on record | Sell | $2.8M | SEC | ||
Alector, Inc.Listing on record | Sell | $8.8M | SEC | ||
Principia Biopharma Inc.Listing unverified | Sell | $30.3M | Unusual size | SEC | |
ARMO BioSciences, Inc.Listing unverified | Other | $185.5M | Unusual size | SEC | |
ARMO BioSciences, Inc.Listing unverified | Other | $20.5M | Unusual size | SEC | |
Audentes Therapeutics, Inc.Listing unverified | Sell | $1.7M | SEC | ||
Audentes Therapeutics, Inc.Listing unverified | Sell | $591.4K | SEC | ||
Audentes Therapeutics, Inc.Listing unverified | Sell | $738.5K | SEC | ||
Audentes Therapeutics, Inc.Listing unverified | Sell | $412K | SEC | ||
Audentes Therapeutics, Inc.Listing unverified | Sell | $2M | SEC | ||
Audentes Therapeutics, Inc.Listing unverified | Sell | $38.4K | SEC | ||
Audentes Therapeutics, Inc.Listing unverified | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Audentes Therapeutics, Inc.Listing unverified | Sell | $111.8K | SEC | ||
Audentes Therapeutics, Inc.Listing unverified | Other | $75.2K | SEC | ||
OTONOMY, INC.Listing unverified | Sell | $2.4M | SEC | ||
OTONOMY, INC.Listing unverified | Sell | $2.3M | SEC | ||
OTONOMY, INC.Listing unverified | Sell | $1M | SEC | ||
OTONOMY, INC.Listing unverified | Sell | $5.8K | SEC | ||
OTONOMY, INC.Listing unverified | Sell | $313.9K | SEC | ||
OTONOMY, INC.Listing unverified | Sell | $3.6M | SEC | ||
Relypsa IncListing on record | Sell | $49.7M | Unusual size | SEC | |
Mirati Therapeutics, Inc.Listing unverified | Buy | $2M | conv 32Cluster | SEC | |
Relypsa IncListing on record | Sell | $1.1M | SEC | ||
Relypsa IncListing on record | Sell | $67.8K | SEC | ||
Relypsa IncListing on record | Sell | $1.2M | SEC |